Results 211 to 220 of about 205,649 (344)
Radiotherapy commissioning and tariff-how can we deliver advanced, innovative, and personalised radiotherapy? [PDF]
Powell Brown I +9 more
europepmc +1 more source
The Biodiversity Moonshot: A Spark for a Transformative Change or a New Business‐Case Facade?
ABSTRACT Biodiversity has recently gained increased attention in sustainability management research. It sustains the ecosystems on which organizations depend, while simultaneously being threatened by organizational activities. By highlighting this dynamic of impact and dependence, the integration of biodiversity into management discourse offers an ...
Francesco Testa +17 more
wiley +1 more source
Expanding the Taxonomy of Ethical Issues in Surgical Innovation
ABSTRACT Surgical innovation poses significant ethical challenges. Previous work has grouped these challenges under four categories: potential harms to patients; compromised informed consent; unfair allocation of healthcare resources; and conflicts of interest. We argue that recent technological developments in surgery warrant the addition of three new
Jane Johnson +2 more
wiley +1 more source
Post-pandemic increase of Group A streptococcal infections in adults: a retrospective cohort study from 2012 to 2024. [PDF]
Lösslein AK +5 more
europepmc +1 more source
Supporting learner agency in collaborative writing with generative AI
Abstract To support learner agency in LLM‐powered writing environments, this research introduces a new interface that integrates two key features: an Argument Outline and a Similarity Viewer. These features were designed to enhance intentionality in writing and self‐monitoring of reliance on AI‐generated suggestions.
Sujin Kim, Hyo‐Jeong So, Kyudong Park
wiley +1 more source
Explainable AI in nuclear medicine. [PDF]
Holm S +17 more
europepmc +1 more source
Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt
Abstract Covalent drug discovery is currently experiencing a boom in industrial and academic interest. To date, at least 75 covalent drugs have received regulatory approval, targeting both traditional target classes and more challenging proteins for which other approaches failed. In many cases, unique aspects of covalent targeting are essential for the
Charles P. Brown +2 more
wiley +1 more source
Drug-resistant TB treatment outcomes and factors associated with discontinuation and LTFU in Germany: No1Lost study protocol. [PDF]
Gödecke M +8 more
europepmc +1 more source

